HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,732 | -12.4% | 19,158 | -1.3% | 0.00% | – |
| Q2 2023 | $22,523 | -28.9% | 19,417 | -7.5% | 0.00% | – |
| Q1 2023 | $31,690 | -41.9% | 20,988 | -2.8% | 0.00% | – |
| Q4 2022 | $54,500 | -35.9% | 21,588 | +6.6% | 0.00% | – |
| Q3 2022 | $85,000 | +46.6% | 20,247 | -3.6% | 0.00% | – |
| Q2 2022 | $58,000 | -49.6% | 21,002 | +4.2% | 0.00% | – |
| Q1 2022 | $115,000 | -39.2% | 20,155 | -3.1% | 0.00% | – |
| Q4 2021 | $189,000 | -58.6% | 20,807 | -51.0% | 0.00% | -100.0% |
| Q3 2021 | $456,000 | -30.1% | 42,491 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $652,000 | +27.1% | 41,943 | +32.6% | 0.00% | 0.0% |
| Q1 2021 | $513,000 | +130.0% | 31,635 | +198.6% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | +77.0% | 10,596 | +24.7% | 0.00% | – |
| Q3 2020 | $126,000 | -1.6% | 8,495 | -2.6% | 0.00% | – |
| Q2 2020 | $128,000 | +456.5% | 8,718 | +343.0% | 0.00% | – |
| Q1 2020 | $23,000 | – | 1,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |